Browsing School of Medicine (MU) by Title "Journal of family practice, 69, no. 10 (December 2020)"
Now showing items 1-1 of 1
-
Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?
(Family Physicians Inquiries Network, 2020)Q: Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone? Evidence-based answer: Yes. Monthly extended-release injectable naltrexone (XR-NTX) treats opioid use disorder as ...